Call Us      +44 (0)20 70961222

Bioinformatics

JOIN OUR APAC 2016
STRATEGY MEETING


19th October 2016 | Shangri-la Hotel, Singapore

OUR UNIQUE FORMAT

The Bioinformatics Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Biomedical Informatics, Scientific Computing and Digital Health (from medium to large Pharma, Biopharma and Biotech players) who aim to accelerate discovery, translational, clinical, CMC, and regulatory programs across the R&D pipeline, as well as thought leaders from Academia and regulatory authorities.

Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– R&D IT, Computational Biology/Sciences, Cloud Computing, Next-Gen Sequencing informatics, Clinical Research and Translational Informatics, Clinical Genomics, Data & Storage Management, Data Computing, Data Visualization & Exploration.

FACILITATORS
Steve-270×260

Steve Rozen

Director & Professor

Duke-NUS Graduate Medical School of Singapore

Lawrence-Wee-270×260

Lawrence Wee

Chief Data Scientist

Zuellig Pharma

Sebastian-Maurer-Stroh-270×260

Sebastian Maurer-Stroh

Programme Director Human Infectious Diseases

Bioinformatics Institute

Zheng-Jye-Ling-270×260

Zheng Jye Ling

Assistant Director

National University Health System

Shyam-Prabhakar-270×260

Shyam Prabhakar

Associate Director of Integrative Genomics

Genome Institute of Singapore

Asif-Khan-270×260 (1)

Asif M. Khan

Dean

Perdana University

Henry-Yang-270×260

Henry Yang

Cancer Science Institute

Head of Bioinformatics Core

Yaron-Turpaz-270×260

Yaron Turpaz

CIO

Human Longevity Inc.

ADVISORY BOARD
james-weatherall1-270×260

James Weatherall

Executive Director & Head, Advanced Data Analytics

AstraZeneca

Bryn-Roberts-270×260

Bryn Roberts

Global Head of Operations and Informatics, Pharmaceutical Research & Early Development

Roche

Quan-Yang

Quan Yang

Global Lead and Director, Biology Information Systems
Hongmei-Huang-270×260

Hongmei Huang

Head of Informatics, Development Sciences

Genentech

WHAT TO EXPECT
roundtable
Interactive Roundtable Discussions

Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.

one to one copy
Director level one-to-one meetings

We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.

agenda
Tailor-fit and Personalized Agenda

Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.

netwkorking copy
Networking Opportunities

Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.

Thank you for reaching Proventa International

One of our executives will contact you within 24 hours

BIOINFORMATICS

STRATEGY MEETING APAC 2016








***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.

BECOME SPONSOR

If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!

WHAT PEOPLE SAY

BIOINFORMATICS Strategy Meeting APAC 2016

Level of Delegation, Bioinformatics Strategy Meeting USA 2015

Return on Investment, Bioinformatics Strategy Meeting USA 2015

Nathalie Jourdan, President & Owner, Bioptimize

Seth Crosby, Director Partnerships & Alliances, Washington University of Medicine

Jane Yu, Founder & CEO, Ageneo

John Apathy, Senior Advisor Healthcare & Life Sciences, IBM

Dominique Salloum, CEO & Founder, Bioptimize

John Apathy, Bioinformatics Strategy Meetings Europe 2014

Sowmyanarayan Srinivasan, Bioinformatics Strategy Meeting Europe 2014

Oleksandr Otava, Bioinformatics Strategy Meeting Europe 2014

Jerome Wojcik, Bioinformatics Strategy Meeting Europe 2014

Abel Ureta-Vidal, Bioinformatics Strategy Meeting Europe 2014

Roundtable Discussion Format, Bioinformatics Strategy Meeting Europe 2015

Yaron Turpaz

Chief Information Officer

Its nice because they basically allowed people to engaged to discussions and questions. Academic and industry is very nice and informative

Ivan John Clement

Data Scientist - R&D

Its good because you really get the people to talk. They are willing to share their knowledge, the juniors are very eager to learn.

Raghuraman Gopal

Manager Quality Assurance

The format is the beginning of breakthrough and integration, the level of delegates is very good and excellent, they learn a lot.

Dadabhai Singh

Founder & President

The kind of interaction is very interactive

Steve Rozen

Director & Professor

Because of diversity we really districts the points and all. People are very diversity and thoughtful in a round table.

THE VENUE

SHANGRI-LA HOTEL
SINGAPORE


Address

22 Orange Grove Rd, Singapore 258350


Phone

+65 6737 3644

OUR MEDIA PARTNERS




james-weatherall1-270×260

James Weatherall

Executive Director & Head, Advanced Data Analytics

AstraZeneca

Bryn-Roberts-270×260

Bryn Roberts

Global Head of Operations and Informatics, Pharmaceutical Research & Early Development

Roche

 

Bryn gained his BSc and PhD in pharmacology from the University of Bristol, UK.  Following post-doctoral work in neuropharmacology, he joined Organon as Senior Scientist in 1996.  A number of roles followed with Zeneca and AstraZeneca, including team and project leader roles in high throughput screening and research informatics.  In 2004 he became head of Discovery Informatics at the AstraZeneca sites in Cheshire, UK.

Bryn joined Roche in Basel in 2006, and his role as Global Head of Informatics was expanded in 2014 to Global Head of Operations for Pharma Research and Early Development.  He is also the Centre Head for the Roche Innovation Centre Basel.

Beyond Roche, Bryn is a Visiting Fellow at the University of Oxford, where he is a member, and former chairman, of the scientific management committee for the Systems Approaches to Biomedical Sciences Centre for Doctoral Training.  He is a member of the Pistoia Alliance board of directors, and was recognised in Fierce Biotech IT’s Top 10 Biotech Techies 2013.

Quan-Yang

Quan Yang

Global Lead and Director, Biology Information Systems

Novartis

Hongmei-Huang-270×260

Hongmei Huang

Head of Informatics, Development Sciences

Genentech

Hongmei joined Genentech in June 2017, and is responsible for the strategic leadership of Development Sciences efforts around informatics systems, data lifecycle management, data standards, analytics infrastructure, and ongoing data operations.

Hongmei is an accomplished Informatics leader with more than 20 years experience in the Pharmaceutical/Biotech Industry. Hongmei received her PhD in BioOrganic Chemistry from The Scripps Research Institute. She started her career as a Research Investigator at Bristol-Myers Squibb, and transitioned into Informatics over the course of her career. Prior to joining Genentech, Hongmei was responsible for strategy formulation, , and delivery of informatics and IT portfolios in partnership with R&D functions globally in various companies including Novartis and Assembly Biosciences.

Steve-270×260

Steve Rozen

Director & Professor, Duke-NUS Graduate Medical School of Singapore

Steve Rozen has made major contributions in the areas of bioinformatics, human genetics & cancer genomics. He created and maintains the widely-used Primer3 software for PCR primer design. He worked extensively on identifying mutations in human Y chromosomes and their clinical consequences, as reported in multiple publications in Nature Genetics and Nature. Rozen founded and directs the Duke-NUS Centre for Computational Biology. The Centre's faculty have published > 140 scientific papers since 2011 and the Centre offers a PhD program in bioinformatics. Rozen's own laboratory focuses on bioinformatics and cancer genomics, and is part of a team-science effort in cancer genomics that has led to multiple papers, including 5 in Nature Genetics.

Lawrence-Wee-270×260

Lawrence Wee

Chief Data Scientist, Zuellig Pharma

Dr. Lawrence Wee is currently the Chief Data Scientist at Zuellig Pharma. He has extensive experience in the research, innovation and commercialization of analytics across bioinformatics and healthcare domains. He has previously taken on the role of head of Biomedical and Healthcare Analytics at the Institute for Infocomm Research and President of the Association for Medical and Bioinformatics Singapore.

Sebastian-Maurer-Stroh-270×260

Sebastian Maurer-Stroh

Programme Director Human Infectious Diseases, Bioinformatics Institute

Coming from Austria, via Belgium to Singapore, Dr. Sebastian Maurer-Stroh leads a group of experts in computational sequence and structure analysis as senior principal investigator in the A*STAR Bioinformatics Institute (BII) since 2007. With more than 110 publications in the field, he is known for developing the currently most comprehensive influenza mutation analysis tool, the FluSurver, which is used by researchers, National Influenza Centres, WHO Collaborating Centres and the GISAID initiative. He is also heading an infectious disease programme that has been involved in local high profile outbreak analyses such as the Hep C cluster in SGH or the first Zika genomes from the Singapore outbreak.

Zheng-Jye-Ling-270×260

Zheng Jye Ling

Assistant Director, National University Health System

Dr Ling Zheng Jye is an ILTC physician who works on improving NUH’s electronic medical records systems to make life better. Combining public health perspectives with user experience design, he enjoys helping the amazing people in Singapore healthcare with tailoring products to fit local workflows. He is currently working on effective use of hospital data to improve outcomes and efficiency. Work is a real joy, because he gets to help his friends deliver care more effectively and happily!

 

Asif-Khan-270×260 (1)

Asif M. Khan

Dean, Perdana University

 

Dr. Khan is currently appointed as the Director of the Perdana University Centre for Bioinformatics (PU-CBi), Malaysia, Acting Dean of the Perdana University School of Data Sciences (PU-SDS), and Visiting Scientist for the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine (JHUSOM), USA. His research interests are in the area of biological data warehousing and applications of bioinformatics to the study of immune responses, vaccines, venom toxins, drug design, and disease biomarkers. He has authored/co-authored more than 40 international, peer-reviewed research and review articles in various international journals, books and conferences, and presented his work at numerous international conferences. He was involved in the of several novel bioinformatics methodologies, tools, and specialized databases, and currently has three patent applications granted. His teaching experiences (2006-2016) have been in bioinformatics, imparting to undergraduate/postgraduate students at the National University of Singapore and to medical and bioinformatics students at Perdana University; and has assisted in the supervision of research projects of more than 50 students. His publications include three peer-reviewed journal articles and two book chapters on bioinformatics education. He has led the curriculum of a unique Postgraduate Diploma in Bioinformatics programme and an MSc (Bioinformatics) programme (by Research at Perdana University, with the aim of providing students the foundation necessary to manage and mine the wealth of available biological data for knowledge discovery. He is currently an ExCo member and Vice President (Corporate) of the Asia-Pacific Bioinformatics Network (APBioNET); he is also a Honorary Director of APBioNET Limited (LTD). His services to the scientific community include as a reviewer for several journals, conferences, and funding agencies, and has donned various important roles in the organization of several local and international bioinformatics conferences, meetings and workshops.

Yaron-Turpaz-270×260

Yaron Turpaz

CIO, Human Longevity Inc.

Chief Information Officer, Human Longevity, Inc. and Managing Director, Human Longevity Singapore.

Dr. Yaron Turpaz is a proven research and IT leader in the biotech and pharma space with hands on experience using computational and informatics platforms for drug discovery and applications. In his role as CIO at Human Longevity, Inc. (HLI), Dr Turpaz is responsible for building and growing the company’s genomic and phenotypic KnowledgebaseTM business, and leads all bioinformatics/informatics and software engineering efforts. Dr Turpaz is expanding informatics program at HLI’s California facility, as well as building a computing and informatics program and facility in Singapore, with a focus on collaborations with the pharmaceutical and healthcare industry. Prior to joining HLI, he worked at AstraZeneca as Vice President, R&D IT; At Eli Lilly Singapore Centre for Drug Discovery as Director of Integrative Computational Sciences, and at Affymetrix, Inc. as Senior Manager, Bioinformatics and Algorithms Development. Dr Turpaz has BS in Biology from Tel Aviv University, a Ph.D. in Bioengineering from the University of Illinois and an MBA from the University of Chicago, Booth School of Business. He also held an adjunct assistant professor at the Centre for Quantitative Medicine of Duke-National University of Singapore, Graduate Medical School in Singapore.

 

Shyam-Prabhakar-270×260

Shyam Prabhakar

Associate Director of Integrative Genomics, Genome Institute of Singapore

Shyam Prabhakar obtained a B.Tech in Electronics Engineering from IIT-Madras and a PhD in Applied Physics from Stanford University. He was the sole recipient of the 2001 American Physical Society thesis award in Beam Physics. As a postdoctoral fellow at the Lawrence Berkeley National Laboratory, he led seminal studies of human evolution before joining the Genome Institute of Singapore, where his group brings data analytics and cutting-edge omics technologies to precision medicine. He is now Associate Director of Integrative Genomics, Head of the Single Cell Omics Centre and co-leader of the A*STAR centre for Big Data and Integrative Genomics (c-BIG).

Henry-Yang-270×260

Henry Yang

Cancer Science Institute, Head of Bioinformatics Core

Dr Henry Yang is currently a research associate professor at Cancer Science Institute of Singapore (CSI), National University of Singapore, and heads the Bioinformatics Core at the institute. His main research focuses are on 1) of effective analysis pipelines for large-scale genomic data; 2) integrative analysis of  expression, splicing, and RNA editing from the transcriptomic data, as well as mutations and epigenetic modifications from genomic and epigenomic data; 3) identification of novel biomarkers and drug targets based on integrative analysis of genomic/transcriptomic data with clinical data; and 4) integrative analysis of large-scale public data sets such as TCGA, 1000Genome, dbGAP and GEO. Prior to joining CSI 4+ years ago, Dr Yang worked as a principal investigator in the area of large-scale transcriptome analysis and integrative analysis for discovery of novel targets/biomarkers and regulatory mechanisms at two A-STAR institutes (Bioinformatics Institute and Singapore Immunology Network) for several years.